Norland's heel bone density test cleared:
This article was originally published in Clinica
Executive Summary
The FDA has cleared Norland Medical Systems' new peripheral bone density measuring device which takes density readings at the heal. The portable Apollo DXA device will cost less than $20,000 and will be marketed at physicians' offices in the US. The company has struck a deal with Tokai Financial Services under which Tokai will provide financing for purchasers of the device.